Saikosaponin B2
Saikosaponin B2 acts on HCV E2 and inhibits infection by several genotypic strains and prevents binding of serum-derived HCV onto hepatoma cells. Saikosaponin B2 (5 μM) induces differentiation of B16 melanoma cells, with potentiation of expressions of tyrosinase and melanogenesis.
| Catalog Number | T3810 |
| Research Area | Others|||Proteases/Proteasome|||Microbiology/Virology |
| Molecular Formula | C42H68O13 |
| CAS# | 58316-41-9 |
| Purity | 99.88% |
| SMILES | C[C@H]1O[C@@H](O[C@H]2CC[C@@]3(C)[C@@H](CC[C@]4(C)[C@@H]3C=CC3=C5CC(C)(C)CC[C@]5(CO)[C@H](O)C[C@@]43C)[C@]2(C)CO)[C@H](O)[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H]1O |
| Size | 5 mg |
| Supplier Page | https://www.targetmol.com/compound/Saikosaponin B2 |
| Additional Information | https://www.targetmol.com/datasheet/T3810 |